Genea Fertility, a leading Australian fertility network, has appointed internationally recognized fertility specialist Associate Professor Gavin Sacks to its medical leadership team. This announcement, made on November 6, 2025, marks a significant addition to Genea’s commitment to clinical excellence that has spanned nearly four decades.
Dr. Sacks brings over 20 years of experience in reproductive medicine, recognized globally for his innovative research in areas such as luteinising hormone (LH) supplementation and advanced sperm selection technologies. His work has had a profound impact on the field, particularly through contributions to reproductive immunology and genomic screening.
Tim Yeoh, CEO of Genea, expressed enthusiasm about Dr. Sacks’ integration into the team, stating, “Dr. Sacks embodies exactly what Genea represents – pushing boundaries with world-class research whilst translating cutting-edge science into better patient outcomes.” His appointment reaffirms the organization’s dedication to pioneering fertility care.
Expertise and Innovative Treatments
Dr. Sacks holds a PhD in reproductive immunology from the University of Oxford and has a subspecialist qualification in Reproductive Medicine from the United Kingdom. His extensive publication record in leading medical journals, along with roles as an Associate Editor for Human Reproduction and Human Reproduction Update, underscores his influence in the field.
He is the creator of the “Bondi Protocol,” a notable immune therapy utilized by fertility specialists across Australia to address challenges like implantation failure and recurrent miscarriage. Dr. Sacks’ research into the immune system’s role in reproductive health has significantly shaped clinical practices, improving outcomes for many patients facing complex fertility issues.
“What attracted me to Genea was their reputation as pioneers in fertility medicine combined with the leading patient outcomes they achieve year after year,” Dr. Sacks stated. He emphasized the importance of personalized care in fertility treatments, affirming that every patient’s journey is unique and deserving of tailored attention.
Collaborative Leadership Approach
Joining forces with Dr. Mark Livingstone and Dr. Myvanwy McIlveen in Genea’s collaborative medical leadership team, Dr. Sacks aims to enhance patient care through innovation and clinical excellence. This integrated leadership model allows Genea to maintain robust governance and a focus on patient outcomes across its national network.
Clinical Associate Professor Mark Bowman, who has previously served as Group Medical Director, will transition to the role of Group Medical Director Emeritus. This ensures continuity of expertise and institutional knowledge during this leadership change.
Dr. Sacks will continue his clinical practice as a fertility specialist at Genea’s clinics located in Sydney CBD and Bondi Junction. He also holds positions as a Visiting Medical Officer at St George Hospital and as a Conjoint Associate Professor at the University of New South Wales. His areas of expertise include unexplained infertility, recurrent miscarriage, and preimplantation genetic testing (PGT).
Dr. Sacks is particularly sought after for second opinions in complex fertility cases. Known for his calm demeanor and meticulous approach, he collaborates closely with patients to develop individualized treatment plans that maximize their chances of success.
Research remains a focal point for Dr. Sacks as he leads initiatives in various areas of reproductive medicine. He has been an early adopter of innovative technologies, including time-lapse embryo monitoring. “Research is how we get to the cutting edge, and that does take courage and imagination,” he noted.
Dr. Sacks is also working on a book titled “The Origin of Hope”, exploring themes related to reproduction and human origins.
Patients interested in consultations with Dr. Gavin Sacks can book appointments through Genea’s website or by calling (02) 8484 7666.
Genea Fertility, with nearly 40 years of experience, is committed to helping individuals realize their dreams of parenthood. The organization continues to blend advanced scientific research with compassionate patient care, achieving leading success rates in IVF and fertility treatments. For further details, visit genea.com.au.
